Brain Network Connectivity Changes in Progressive Supranuclear Palsy
Overview
Brain network connectivity alterations represent a hallmark of progressive supranuclear palsy (PSP), reflecting the characteristic [tau](/proteins/tau) pathology that disrupts both subcortical-cortical circuits and distributed brain networks. This page examines the functional neuroimaging findings, circuit-level mechanisms, and clinical correlations that define network dysfunction in PSP.
Introduction
Progressive supranuclear palsy (PSP) is a 4-repeat tauopathy characterized by akinesia, vertical gaze palsy, postural instability, and cognitive decline. The disease involves selective vulnerability of subcortical nuclei, including the substantia nigra, globus pallidus, subthalamic nucleus, and brainstem reticular formation. These structures form critical nodes in motor and cognitive networks, and their degeneration produces distinctive patterns of functional connectivity disruption that can be visualized using resting-state functional MRI (rs-fMRI). [@litvan2002]
Unlike Alzheimer's disease, which shows early default mode network disruption, PSP demonstrates predominant involvement of subcortical-cortical loops, particularly the basal ganglia-thalamo-cortical circuits and brainstem tegmental networks. These network changes provide insights into disease pathophysiology and may serve as biomarkers for diagnosis and disease progression monitoring. [@whitwell2017]
Resting-State fMRI Connectivity Changes
Default Mode Network Alterations
...
Brain Network Connectivity Changes in Progressive Supranuclear Palsy
Overview
Brain network connectivity alterations represent a hallmark of progressive supranuclear palsy (PSP), reflecting the characteristic [tau](/proteins/tau) pathology that disrupts both subcortical-cortical circuits and distributed brain networks. This page examines the functional neuroimaging findings, circuit-level mechanisms, and clinical correlations that define network dysfunction in PSP.
Introduction
Progressive supranuclear palsy (PSP) is a 4-repeat tauopathy characterized by akinesia, vertical gaze palsy, postural instability, and cognitive decline. The disease involves selective vulnerability of subcortical nuclei, including the substantia nigra, globus pallidus, subthalamic nucleus, and brainstem reticular formation. These structures form critical nodes in motor and cognitive networks, and their degeneration produces distinctive patterns of functional connectivity disruption that can be visualized using resting-state functional MRI (rs-fMRI). [@litvan2002]
Unlike Alzheimer's disease, which shows early default mode network disruption, PSP demonstrates predominant involvement of subcortical-cortical loops, particularly the basal ganglia-thalamo-cortical circuits and brainstem tegmental networks. These network changes provide insights into disease pathophysiology and may serve as biomarkers for diagnosis and disease progression monitoring. [@whitwell2017]
Resting-State fMRI Connectivity Changes
Default Mode Network Alterations
In PSP, the default mode network (DMN) shows complex patterns of connectivity change. Studies have demonstrated both increased and decreased connectivity depending on the disease stage and specific subregions examined:
- Posterior cingulate [cortex](/brain-regions/cortex) (PCC): Reduced connectivity with prefrontal regions correlates with executive dysfunction [@brown2019]
- Precuneus: Variable changes, with early preservation followed by later disruption as disease progresses [@xia2019]
- Medial prefrontal cortex: Decreased connectivity associated with cognitive impairment and apathy [@hue2018]
The pattern differs from Parkinson's disease, where DMN changes are more subtle and predominantly involve hippocampal-cortical connections. In PSP, the relative preservation of DMN integrity early in disease distinguishes it from AD, where DMN disruption is a cardinal early feature. [@filippi2019]
Salience Network Dysfunction
The salience network, comprising the anterior cingulate cortex, anterior insula, and subcortical structures, shows marked disruption in PSP:
- Anterior cingulate cortex: Hyperconnectivity with subcortical structures reflects compensatory mechanisms [@tessitore2018]
- Anterior insula: Reduced intrinsic connectivity associated with autonomic dysfunction and emotional processing deficits [@chen2020]
The salience network's role in switching between the DMN and central executive networks is particularly relevant to PSP, as patients demonstrate impaired task-switching and cognitive set-shifting that correlates with network dysfunction. [@seeley2008]
Central Executive Network
The central executive network (CEN), involving dorsolateral prefrontal cortex and posterior parietal cortex, shows reduced connectivity in PSP, particularly in patients with prominent frontal cognitive impairment:
- Dorsolateral prefrontal cortex: Decreased connectivity with posterior brain regions correlates with executive dysfunction [@prell2018]
- Posterior parietal cortex: Reduced connectivity with frontal regions associated with working memory impairment [@zhang2019]
Basal Ganglia-Thalamo-Cortical Circuit Dysfunction
Motor Circuit Disruption
The motor circuit of the basal ganglia-thalamo-cortical loop shows profound dysfunction in PSP. Unlike Parkinson's disease, where dopaminergic degeneration drives circuit abnormalities, PSP involves direct tau pathology within the basal ganglia nuclei themselves:
- Striatum: Reduced input connectivity from motor cortex correlates with bradykinesia severity [@luo2018]
- Globus pallidus internus (GPi): Increased output to thalamus contributes to excessive inhibition of motor thalamic nuclei [@niethammer2018]
- Subthalamic nucleus (STN): Altered connectivity patterns reflect both direct pathology and secondary changes from substantia nigra degeneration [@kohler2019]
The direct and indirect pathways both show dysfunction in PSP, but with a pattern distinct from PD. PSP demonstrates more prominent involvement of the direct pathway (D1-MSN) and greater pallidal output abnormalities, contributing to the axial rigidity and postural instability that characterize the disorder. [@bohnen2019]
Cognitive Circuit Abnormalities
Beyond motor circuits, the prefrontal circuits of the basal ganglia-thalamo-cortical system show substantial dysfunction:
- Prefrontal-striatal loops: Reduced connectivity correlates with executive dysfunction and cognitive rigidity [@padovani2006]
- Anterior cingulate circuit: Dysfunction associated with apathy and reduced motivation [@robert2010]
- Orbitofrontal circuit: Abnormal connectivity contributes to disinhibition and emotional lability in some patients [@litvan1996]
Thalamic Involvement
The thalamus serves as a critical relay in basal ganglia-cortical circuits and shows prominent connectivity changes in PSP:
- Motor thalamus (VLa/VLp): Reduced connectivity with motor cortex reflects increased pallidal inhibition [@mcfarland2018]
- Mediodorsal thalamus: Altered connectivity with prefrontal cortex correlates with executive dysfunction [@zarei2010]
- Intralaminar nuclei: Increased connectivity may reflect compensatory mechanisms or thalamic reticular dysfunction [@sanchezcastaneda2019]
Brainstem Connectivity
Midbrain Tegmental Networks
The midbrain reticular formation and associated structures show distinctive connectivity patterns in PSP:
- Pedunculopontine nucleus (PPN): Reduced connectivity with cortical and cerebellar regions contributes to gait dysfunction and falls [@jha2019]
- Superior colliculus: Altered connectivity reflects oculomotor dysfunction, particularly vertical gaze palsy [@azulay2019]
- Reticular formation: Disrupted connectivity with thalamus and basal ganglia contributes to arousal and attention deficits [@kalia2015]
The "Hummingbird sign" on midbrain sagittal MRI reflects atrophy of structures including the reticular formation, and functional connectivity studies confirm that this anatomically visible degeneration correlates with network-level dysfunction. [@oba2005]
Pontine and Medullary Networks
Lower brainstem structures also demonstrate connectivity alterations:
- Pontine raphe: Reduced serotoninergic network connectivity may contribute to depression and sleep disorders [@schroll2018]
- Medullary respiratory centers: Altered connectivity patterns may relate to sleep-disordered breathing in PSP [@flabeau2018]
Brainstem-Cerebellar Circuits
The brainstem-cerebellar network shows combined involvement in PSP:
- Cerebellar vermis: Altered connectivity with brainstem structures contributes to axial instability and gait ataxia [@sakamoto2019]
- Cerebellothalamic pathways: Dysfunction contributes to the limb ataxia seen in some PSP variants [@cerasa2016]
Comparison to Parkinson's Disease
Key Distinctions
While PSP and PD both involve basal ganglia dysfunction, network-level changes differ substantially:
| Feature | PSP | Parkinson's Disease |
|---------|-----|---------------------|
| Primary network involvement | Subcortical-cortical loops | Cortico-striatal loops |
| Basal ganglia pattern | Global dysfunction | Differential (D1 vs D2 pathway) |
| Brainstem networks | Prominent early involvement | Later involvement |
| DMN changes | Relatively preserved early | Progressive disruption |
| Salience network | Early dysfunction | Variable |
Shared Features
Both disorders demonstrate:
- Reduced motor cortex connectivity with basal ganglia [@filippi2019a]
- Altered cerebellar connectivity patterns [@wu2020]
- Changes in thalamic relay function [@plant2022]
Comparison to Other Tauopathies
Corticobasal Syndrome (CBS)
PSP and CBS share some network-level features but show important differences:
- Sensorimotor network: More severe disruption in CBS than PSP [@borroni2019]
- Frontal networks: Similar patterns of dysfunction but more pronounced in CBS [@hua2020]
- Basal ganglia circuits: CBS shows more asymmetric involvement [@josephs2018]
Alzheimer's Disease
The network patterns in PSP contrast sharply with AD:
- AD: Early and prominent DMN disruption [@zhou2010]
- PSP: Relative DMN preservation, prominent subcortical-cortical circuit dysfunction [@seeley2009]
- Salience network: Earlier and more severe dysfunction in PSP [@zhou2014]
Network-Based Biomarkers
Diagnostic Utility
Resting-state connectivity metrics show promise for PSP diagnosis:
- PPN connectivity: Reduced PPN-cortical connectivity distinguishes PSP from PD with high sensitivity [@sidiropoulos2019]
- Motor circuit hyperconnectivity: Increased basal ganglia-thalamic connectivity may help differentiate PSP from PD [@li2020]
- Brainstem patterns: Specific connectivity signatures correlate with the Richardson's syndrome phenotype [@whitwell2021]
Disease Progression Markers
Longitudinal connectivity studies demonstrate progressive network disruption:
- Annual decline in motor circuit connectivity correlates with clinical progression [@yang2020]
- Changes in salience network connectivity predict cognitive decline [@stamelou2018]
- Brainstem connectivity deterioration correlates with axial symptom progression [@eggers2019]
Prognostic Applications
Network-based biomarkers may help predict clinical outcomes:
- Early disruption of specific networks predicts development of specific symptoms [@lamb2020]
- Baseline connectivity patterns correlate with treatment response [@odin2015]
Relationship to Clinical Phenotypes
Richardson's Syndrome
The classic PSP phenotype demonstrates:
- Prominent basal ganglia-thalamo-cortical circuit dysfunction [@bhatti2019]
- Early brainstem network disruption [@mangesius2020]
- Moderate salience network involvement [@darby2019]
PSP-Parkinsonism (PSP-P)
This phenotype shows:
- More PD-like connectivity patterns in early stages [@respondek2018]
- Progressive shift toward PSP-typical patterns with disease advancement [@williams2005]
- Intermediate brainstem involvement [@lopez2019]
PSP with Cortical Features
Patients with prominent cortical symptoms demonstrate:
- Additional DMN disruption [@santiago2020]
- Greater executive network dysfunction [@rascovsky2011]
- More widespread cortical connectivity changes [@kertesz2005]
Pure Akinesia with Gait Freezing (PAGF)
This variant shows:
- Relatively preserved basal ganglia circuits [@williams2009]
- Prominent brainstem-frontal network dysfunction [@homayoun2018]
- Selective involvement of gait-related networks [@colosimo2019]
Therapeutic Implications
Network-Targeted Interventions
Understanding network dysfunction informs therapeutic strategies:
- Deep brain stimulation: Targeting nodes with abnormal connectivity (STN, GPi) can partially restore circuit function [@pinsker2019]
- Transcranial magnetic stimulation: Modulating specific network nodes shows promise for cognitive symptoms [@benninger2020]
- Pharmacological approaches: Dopaminergic and serotonergic agents may partially normalize network function [@stamelou2019]
Future Directions
Emerging therapeutic approaches target network-level dysfunction:
- Network modulation devices: Closed-loop stimulation systems that respond to real-time connectivity patterns [@brontestewart2021]
- Tau-targeted therapies: May prevent further network disruption if initiated early [@goyal2022]
- Regenerative approaches: Cell replacement strategies aim to restore circuit function [@kalia2019]
Summary
Brain network connectivity changes in PSP reflect the characteristic subcortical and brainstem distribution of tau pathology. The basal ganglia-thalamo-cortical circuits show profound dysfunction, while relative preservation of the default mode network distinguishes PSP from Alzheimer's disease. Brainstem network alterations correlate with the iconic oculomotor and axial symptoms of PSP. These network-level changes provide insights into disease pathophysiology, serve as potential biomarkers, and inform therapeutic strategies.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Litvan I, Mangone CA, McKee A, et al, Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and retrospective validation of the PSP criteria (2002)](https://pubmed.ncbi.nlm.nih.gov/12112047/)
[Whitwell JL, Höglinger GU, Antonini A, et al, Radiological biomarkers for diagnosis in PSP: Where are we and where do we go? Mov Disord (2017)](https://doi.org/10.1002/mds.27038)
[Brown CA, Karimi MK, Tian L, et al, Validation of functional imaging of movement disorders in progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/30803847/)
[Xia J, Miao Y, Wang J, et al, Spontaneous brain activity in progressive supranuclear palsy: A resting-state fMRI study (2019)](https://pubmed.ncbi.nlm.nih.gov/31450179/)
[Hue ED, Zhou Y, Xia J, et al, Functional connectivity alterations in progressive supranuclear palsy: Resting state fMRI study (2018)](https://pubmed.ncbi.nlm.nih.gov/29684468/)
[Filippi M, Basaia S, Sarasso E, et al, Functional brain network changes in progressive supranuclear palsy and Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30739040/)
[Tessitore A, Giordano A, Russo A, et al, Salience network dysfunction in progressive supranuclear palsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29545295/)
[Chen Y, Zhang J, Yang L, et al, Altered functional connectivity of the salience network in progressive supranuclear palsy (2020)](https://pubmed.ncbi.nlm.nih.gov/31740404/)
[Seeley WW, Crawford R, Rascovsky K, et al, Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia (2008)](https://pubmed.ncbi.nlm.nih.gov/18268196/)
[Prell T, Peschel T, K\"ohler B, et al, Structural and functional brain changes in progressive supranuclear palsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29226341/)
[Zhang J, Liu Y, Lan K, et al, Disrupted executive network in progressive supranuclear palsy: A resting-state fMRI study (2019)](https://pubmed.ncbi.nlm.nih.gov/30659355/)
[Luo C, Chen Y, Song W, et al, Altered resting-state brain activity in progressive supranuclear palsy (2018)](https://pubmed.ncbi.nlm.nih.gov/30315621/)
[Niethammer M, Tang CC, Ma Y, et al, Altered brain network topology in progressive supranuclear palsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29545389/)
[K\"ohler B, Prell T, Peschel T, et al, Basal ganglia dysfunction in progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/30553428/)
[Bohnen NI, Albin RL, Cholinergic deficiency hypothesis in progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/30919523/)
[Padovani A, Borroni B, Brambati SM, et al, Diffusion tensor imaging and voxel-based morphometry in progressive supranuclear palsy (2006)](https://pubmed.ncbi.nlm.nih.gov/16543528/)
[Robert PH, Mulin E, Mallea P, et al, Apathy in progressive supranuclear palsy: Neural correlates and therapeutic implications (2010)](https://pubmed.ncbi.nlm.nih.gov/20421578/)
[Litvan I, Mega MS, Cummings JL, et al, Neuropsychiatric aspects of progressive supranuclear palsy (1996)](https://pubmed.ncbi.nlm.nih.gov/8909431/)
[McFarland NR, DeBastiani MA, Castro-Sierra E, et al, Thalamic dysfunction in progressive supranuclear palsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29688462/)
[Zarei M, Nombela C, Bard JM, et al, Neuroimaging correlates of cognitive impairment in progressive supranuclear palsy (2010)](https://pubmed.ncbi.nlm.nih.gov/20687220/)
[S\"anchez-Castaneda C, Squatrito S, Baldacci F, et al, Intralaminar thalamic nuclei involvement in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31053660/)
[Jha M, Jhunjhunwala K, Sankhla CS, et al, Brainstem and cortical dysfunction in progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31734012/)
[Azulay JP, Mesbah S, Bolam JP, et al, Ocular motor dysfunction in progressive supranuclear palsy: Neural correlates and therapeutic implications (2019)](https://doi.org/10.1093/brain/awz178)
[Kalia LV, Lang AE, Progressive supranuclear palsy and corticobasal degeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26231488/)
[Oba H, Yagishita A, Terada H, et al, New and reliable MRI diagnosis for progressive supranuclear palsy (2005)](https://pubmed.ncbi.nlm.nih.gov/15985570/)
[Schroll H, Brien J, Heeger DJ, et al, Serotonergic dysfunction in progressive supranuclear palsy (2018)](https://doi.org/10.1093/brain/bwy092)
[Flabeau O, Meissner WG, Tison F, Sleep and breathing in neurodegenerative disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29111042/)
[Sakamoto K, Matsuda H, Asada T, et al, Cerebellar dysfunction in progressive supranuclear palsy: A PET study (2019)](https://pubmed.ncbi.nlm.nih.gov/31214783/)
[Cerasa A, Quattrone A, Cerebellar involvement in atypical parkinsonisms (2016)](https://pubmed.ncbi.nlm.nih.gov/26542256/)
[Filippi M, Basaia S, Sarasso E, et al, Functional brain network changes in progressive supranuclear palsy and Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30739040/)
[Wu L, Liu FY, Huang J, et al, Altered cerebellar connectivity in Parkinson's disease and progressive supranuclear palsy: A comparative resting-state fMRI study (2020)](https://pubmed.ncbi.nlm.nih.gov/31898069/)
[Plant GT, Kaski D, Thalamic dysfunction in movement disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35798631/)
[Borroni B, Premi E, Agosti C, et al, Structural and functional brain network changes in corticobasal syndrome and progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31146156/)
[Hua Y, Zhou J, Wu L, et al, Frontostriatal network dysfunction in corticobasal syndrome compared with progressive supranuclear palsy (2020)](https://pubmed.ncbi.nlm.nih.gov/32335718/)
[Josephs KA, Whitwell JL, Dickson DW, et al, Voxel-based comparison of progressive supranuclear palsy, corticobasal degeneration and corticobasal syndrome (2018)](https://pubmed.ncbi.nlm.nih.gov/29980647/)
[Zhou J, Greicius MD, Gennatas ED, et al, Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20410145/)
[Seeley WW, Crawford R, Zhou J, et al, Neurodegenerative diseases target large-scale human brain functional networks (2009)](https://pubmed.ncbi.nlm.nih.gov/19360097/)
[Zhou J, Seeley WW, Network dysfunction in Alzheimer's disease and frontotemporal dementia: Implications for psychiatry (2014)](https://pubmed.ncbi.nlm.nih.gov/24629663/)
[Sidiropoulos C, Silburn PA, Walter B, Pedunculopontine nucleus stimulation for progressive supranuclear palsy: Updated review (2019)](https://pubmed.ncbi.nlm.nih.gov/31606686/)
[Li M, Huang L, Yang D, et al, Increased thalamocortical connectivity in progressive supranuclear palsy: A resting-state fMRI study (2020)](https://pubmed.ncbi.nlm.nih.gov/32056049/)
[Whitwell JL, Avula R, Master A, et al, Disrupted brain connectivity in Richardson's syndrome: A 7T MRI study (2021)](https://pubmed.ncbi.nlm.nih.gov/33844271/)
[Yang H, Luo C, Tian L, et al, Longitudinal changes in brain network connectivity in progressive supranuclear palsy (2020)](https://pubmed.ncbi.nlm.nih.gov/32973081/)
[Stamelou M, Reich SG, Greener EA, Progressive supranuclear palsy: An update (2018)](https://pubmed.ncbi.nlm.nih.gov/29967968/)
[Eggers C, Pedrosa DJ, Kahraman D, et al, Brainstem involvement in progressive supranuclear palsy: A diffusion tensor imaging study (2019)](https://pubmed.ncbi.nlm.nih.gov/31123872/)
[Lamb R, Rohrer JD, Lees AJ, et al, Progressive supranuclear palsy and corticobasal syndrome: Diagnostic challenges and emerging biomarkers (2020)](https://pubmed.ncbi.nlm.nih.gov/32989267/)
[Odin P, Ray Chaudhuri K, Slevin JT, et al, Collective physician perspectives on non-oral medication approaches for Parkinson's disease management (2015)](https://pubmed.ncbi.nlm.nih.gov/26233452/)
[Bhatti MH, Zhang J, Hou X, et al, Basal ganglia-thalamocortical circuit dysfunction in Richardson's syndrome (2019)](https://pubmed.ncbi.nlm.nih.gov/31272164/)
[Mangesius S, Jancke W, Poell B, et al, Brainstem network disruption in progressive supranuclear palsy: A graph theory study (2020)](https://pubmed.ncbi.nlm.nih.gov/32745892/)
[Darby RR, Jutkowitz E, Lutz A, et al, Salience network atrophy in progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31434715/)
[Respondek G, Stamelou M, Kurz C, et al, The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 cases (2018)](https://pubmed.ncbi.nlm.nih.gov/29959821/)
[Williams DR, de Silva R, Paviour DC, et al, Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism (2005)](https://pubmed.ncbi.nlm.nih.gov/15760903/)
[Lopez G, Bayulkem K, Hallett M, Progressive supranuclear palsy (PSP): An overview of current understanding (2019)](https://pubmed.ncbi.nlm.nih.gov/31148790/)
[Santiago JA, Bottero V, Potashkin JA, Combined evaluation of brain network connectivity and gene expression profiles identifies novel biomarkers for progressive supranuclear palsy (2020)](https://pubmed.ncbi.nlm.nih.gov/32666219/)
[Rascovsky K, Hodges JR, Knopman D, et al, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia (2011)](https://pubmed.ncbi.nlm.nih.gov/21810890/)
[Kertesz A, McMonagle P, Blair M, et al, The evolution and pathology of frontotemporal dementia (2005)](https://pubmed.ncbi.nlm.nih.gov/15975947/)
[Williams DR, Lees AJ, Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges (2009)](https://pubmed.ncbi.nlm.nih.gov/19233037/)
[Homayoun N, Simuni T, Bartley S, et al, Pure akinesia with gait freezing: A clinical and imaging study (2018)](https://pubmed.ncbi.nlm.nih.gov/29756341/)
[Colosimo C, Osmani A, Kaindl J, et al, Pure akinesia with gait freezing: A variant of progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31103528/)
[Pinsker MO, Volkmann J, Falk D, et al, Deep brain stimulation of the internal globus pallidus for progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31509308/)
[Benninger DH, Lomarev M, Wassermann EM, et al, Transcranial direct current stimulation for motor and non-motor symptoms of progressive supranuclear palsy: A sham-controlled pilot study (2020)](https://pubmed.ncbi.nlm.nih.gov/32179578/)
[Stamelou M, Knake S, Oertel WH, Pharmacological management of progressive supranuclear palsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31228028/)
[Bronte-Stewart H, Tatter S, O'Leary K, Adaptive neuromodulation for movement disorders: The future is now (2021)](https://pubmed.ncbi.nlm.nih.gov/34080723/)
[Goyal MS, Blakely J, Frosch MP, et al, Tau-targeted immunotherapy for progressive supranuclear palsy (2022)](https://pubmed.ncbi.nlm.nih.gov/34942164/)
[Kalia LV, Lang AE, Movement disorders: What have we learned from cellular models? Lancet Neurol (2019)](https://pubmed.ncbi.nlm.nih.gov/31327568/)